References
- Ruiz LA, Serrano L, España PP, Martinez-Indart L, Gómez A, et al. New-onset atrial fibrillation in patients with pneumococcal pneumonia. ımpact of timing and duration on short-and medium-term mortality. J Infect. 2021;82(1):67–75.
- Bağcı A, Aksoy F. Systemic immune-inflammation index predicts new-onset atrial fibrillation after st elevation myocardial infarction. Biomark Med. 2021;15(10):731–739.
- Disertori M, Lombardi F, Barlera S, Maggioni AP, Favero C, et al. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the gruppo ıtaliano per lo studio della sopravvivenza nell’ınfarto miocardico-atrial fibrillation (GISSI-AF) Trial. Am Heart J. 2011;162:382–389.
- Quiroga W, Conci E, Zelaya F, Isa M, Pacheco G, et al. Estratificación del riesgo en el infarto agudo de miocardio según el índice leucoglucémico.¿ El Killip-Kimball de laboratorio. Rev Fed Arg Cardiol. 2010;39.1:29–34.
- Sadeghi R, Aghajani MH, Parandi R, Taherpour N, Ahmadzadeh K, et al. Leuko-glycemic ındex in the prognosis of acute myocardial ınfarction; a cohort study on coronary angiography and angioplasty registry. Archives of Academic Emergency Medicine. 2023;11(1).
- Martínez García G. Hiperglucemia y leucocitosis c-como predictores d-de complicaciones intrahospitalarias en pacientes con ınfarto del miocardio agudo. Revista Habanera de Ciencias Médicas. 2021;20(6).
- Jani Y, Haxhirexha K, Pocesta B, Pocesta B, Rexhepi A, et al. Impact of ınflammation on atrial fibrillation in patients with metabolic syndrome. J Cardiology Interventions. 2021;2(01):1–8.
- Schnabel RB, Larson MG, Yamamoto JF, Sullivan LM, Pencina MJ, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010;121 (2):200–207.
- Nso N, Bookani KR, Metzl M, Radparva F. Role of ınflamation in atrial fibrillation: a comprehensive review of current knowledge. J Arrhythmia. 2021;37(1):1–10.
- Zheng RJ, Wang Y, Tang JN, Duan JY, Yuan MY, et al. prognostic value of systemic ımmune-ınflammation ındex (sıı) as a novel marker in patients with atrial fibrillation. Authorea Preprints. 2024.
- Batta A, Hatwal J, Panda P, Sharma Y, Wander GS, et al. Impact of ınitial high sensitivity c-reactive protein on outcomes in nonvalvular atrial fibrillation: an observational study. Future Cardiology. 2024;1–9.
- Hadi AR, Alawi A, Wael AL, Jassim M. Inflammatory cytokines and atrial fibrillation: current and prospective views. Journal of Inflammation Research. 2010:75–97.
- Yo CH, Lee SH, Chang SS, Chang SS, Lee MCH, et al. Value of high-sensitivity c-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis. BMJOpen. 2014;4(2):e004418.
- Meyre PB, Sticherling C, Spies F, Aeschbacher S, Blum S, et al. C-reactive protein for prediction of atrial fibrillation recurrence after catheter ablation. BMC Cardiovasc Disord. 2020;20(1):1–9.
- Jani Y, Neziri E, Paparisto S, Bara P, Haxhirexha K, et al. Use of c-reactive protein for prediction of sinus rhythm maintenance after pharmacologic cardioversion in patients with metabolic syndrome. Romanian Journal of Cardiology. 2024;34(1), 24–30.
- Medi C, Kalman JM, Spence SJ, Teh AW, Lee G, et al. Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. Journal of Cardiovascular Electrophysiology. 2011;22(12):1317–1324.
- Tyan L, Mesquitta WM, Grimes AC, Balijepalli RC. Long QT syndrome-associated Caveolin-3 mutation F97C imparts a loss-of-function effect on cardiac transient outward potassium current (ITO). Heart Rhythm. 2014;11(11):2132.
- Kuga K, Yamasaki H, Hattori A, Xu DZ, Watanabe S, et al. Prognosis of myocardial infarction with left ventricular dysfunction in the coronary revascularization era–subanalysis of the Japanese Coronary Artery Disease (JCAD) study. Circulation Journal 2014;78(10):2483–2491.
- Kutyifa V, Thomsen PEB, Huang DT, Rosero S, Tompkins C, et al. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Heart Rhythm. 2013;10(12):1770–1777.
- Karabağ T, Mutlu F, Efe SÇ. Fibrosis-4 ındex for prediction of the severity of acute pulmary embolism: cross-sectional research. Türkiye Klinikleri Cardiovascular Sciences. 2021;33(2).